Biologikanebenwirkungen bei Psoriasis
Beteiligte Einrichtungen
Abstract
Aim. Typical side effects and significant risks of antipsoriatic biologic therapies considering psoriatic control groups are presented.
Materials and methods. A selective literature search was conducted in PubMed and long-term safety studies of the psoriasis registries PsoBest, PSOLAR and BADBIR were evaluated.
Results and discussion. To assess the long-term safety of biologics, the evaluation of the course of large patient cohorts in long-term registries is of particular medical importance. Newer biologic drugs seem to exhibit a better safety profile than older ones.
Bibliografische Daten
Titel in Übersetzung | Side effects of biologic therapies in psoriasis |
---|---|
Originalsprache | Deutsch |
ISSN | 0017-8470 |
DOIs | |
Status | Veröffentlicht - 04.2018 |
PubMed | 29568996 |
---|